冠军肿瘤 CSBR 深 沪
等待开盘 05-12 09:30:00 美东时间
6.08
+0.125
+2.10%
华盛通- 最 高6.30
- 今 开6.00
- 成交量 3.86万股
- 最 低 5.83
- 昨 收 5.955
- 总市值 8.22万
- 52周最高 9.6299
- 市盈率 静 157.11
- 换手率 285.25%
- 52周最低 5.50
- 委 比 70.21%
- 总股本 1.35万
- 历史最高 19.80
- 量 比 3.40
- 振 幅 7.89%
- 历史最低 0.00
- 每 手 1
- 风险率 0.67%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For March 12, 2026
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
Earnings Scheduled For December 15, 2025
Companies Reporting Before The Bell • MindWalk Holdings (NASDAQ:HYFT) is likely...
2025-12-15 19:11
Argenx, Navan And 3 Stocks To Watch Heading Into Monday
Stock futures up, focus on HYFT, ARGX, NAVN, AXR, CSBR as they report earnings. Top 2 energy stocks to watch for potential plunge this month.
2025-12-15 15:42
Insights Ahead: Champions Oncology's Quarterly Earnings
Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings r...
2025-12-12 22:01
Earnings Scheduled For March 11, 2025
Companies Reporting Before The Bell • Exagen (NASDAQ:XGN) is projected to repor...
2025-03-11 16:32
Market-Moving News for September 12th
CSBR: 59% | Champions Oncology shares are trading higher after the company reported better-than-expected Q1 financial results. Also, Craig-Hallum upgraded the stock from Hold to Buy and maintained its $6 price
2024-09-12 20:08
Craig-Hallum Upgrades Champions Oncology to Buy, Maintains Price Target to $6
Craig-Hallum analyst Matt Hewitt upgrades Champions Oncology (NASDAQ:CSBR) from Hold to Buy and maintains the price target from $6 to $6.
2024-09-12 19:18
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Shares of Champions Oncology, Inc. (NASDAQ:CSBR) rose sharply in today's pre-ma...
2024-09-12 17:46
Kroger, Adobe And 3 Stocks To Watch Heading Into Thursday
With U.S. stock futures trading higher this morning on Thursday, some of the st...
2024-09-12 14:45
Champions Oncology Q1 Adj $0.11 Beats $(0.03) Estimate, Sales $14.06M Beat $13.23M Estimate
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(0.03) by 466.67 percent. This is a 168.75 percent increase over losses of $(0.16) per share
2024-09-12 04:04
